Sun Pharmaceutical Industries Share Price Today - Live Blog for April 23, 2025

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.12% uptick in its share price. As a result, it's now actively trading at ₹1,790.00 per share, making it an attractive option for investors.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.23% decline and is currently trading at ₹1,787.90 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

After a significant 0.26% gain, Sun Pharmaceutical Industries Ltd's shares are now valued at ₹1,789.50 in the current market. This upward movement is attracting attention from both retail and institutional investors.

After a notable 0.15% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,784.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

The share price of Sun Pharmaceutical Industries Ltd recently experienced a positive upturn, resulting in a 0.02% increase. Presently, it is actively trading at ₹1,781.80.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.07%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,781.50, but investors are assessing whether this is a temporary dip or a long-term trend.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.08%, with its current market value per share resting at ₹1,783.00. This development highlights the stock's appeal to investors.

Demonstrating a commendable 0.22% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,782.00. In terms of valuation, the stock maintains a PE ratio of 36.6000, while the industry PE ratio stands at 33.9840.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.06%, reaching a current market price of ₹1,778.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd share price has declined by -0.09%, and it's currently trading at ₹1,778.45. The stock maintains a PE of 36.6000, while the industry PE is 33.9840, prompting discussions about its valuation.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.31% increase in its share price and is currently trading at ₹1,780.00. This remarkable performance has caught the eye of investors.

After a notable 0.19% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,776.35. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

Sun Pharmaceutical Industries Ltd shares saw a -0.18% decrease, reaching a current market price of ₹1,772.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 36.6000, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.27%, and it is currently trading at ₹1,775.00. Additionally, the stock maintains a PE ratio of 36.6000, while the industry PE is 33.9840.

The share price of Sun Pharmaceutical Industries Ltd soared by an impressive 0.01%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,770.25 per share.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.53%, reaching the current market value of ₹1,770.00 per share. This surge is a testament to the stock's recent performance.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.05% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,760.70 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.28%, reaching a current market price of ₹1,760.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.05% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,765.00 per share. The stock has an ROE of 15.9938% and debt to equity ratio of 0.0372.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.07% drop, and it's now trading at ₹1,765.65 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.05%, reaching the current market value of ₹1,766.45 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd observed a remarkable 0.01% surge in its share price and is presently trading at ₹1,767.20. The increased investor interest is driving this surge.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.63%, reaching the current market value of ₹1,763.00 per share. This surge is a testament to the stock's recent performance.

Sun Pharmaceutical Industries Ltd witnessed a -0.08% drop in its share price and is currently trading at ₹1,751.95. With the stock's PE at 36.6000 and the industry PE at 33.9840, investors are weighing their options.

After a notable 0.13% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,754.35. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

The stock of Sun Pharmaceutical Industries Ltd has experienced a -1.75% drop, and it's now trading at ₹1,753.85 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.